Breaking News Instant updates and real-time market news.

LSPD

Lightspeed

$55.08 /

+3.96 (+7.75%)

17:57
11/29/20
11/29
17:57
11/29/20
17:57

Lightspeed downgraded to Neutral from Buy at BTIG

BTIG analyst Mark Palmer downgraded Lightspeed to Neutral from Buy after the company's share price exceeded his previous C$58 target. The analyst notes that shares have surged by 376% since he initiated coverage of the stock amidst the pandemic-driven March lows, including an increase of more than 68% during the past month versus a 7.0% increase in the S&P 500 during that span. Palmer remains constructive on Lightspeed's growth prospects as its cloud-based point-of-sale and payments offerings are rolled out to a $100B-plus restaurant and retail market. However, he believes a significant portion of that upside is already reflected in the stock's valuation.

  • 30

    Nov

  • 11

    Sep

LSPD Lightspeed
$55.08 /

+3.96 (+7.75%)

11/09/20 RBC Capital
Lightspeed price target raised to $56 from $47 at RBC Capital
11/06/20 CIBC
Lightspeed price target raised to C$67 from C$50 at CIBC
11/06/20 BMO Capital
Lightspeed price target raised to C$62 from C$50 at BMO Capital
11/06/20 Scotiabank
Lightspeed price target raised to C$56 from C$51 at Scotiabank

TODAY'S FREE FLY STORIES

Recommendations
Skyworks price target raised to $165 from $150 at Barclays » 06:51
01/26/21
01/26
06:51
01/26/21
06:51
SWKS

Skyworks

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWKS Skyworks
/

+

SWKS Skyworks
/

+

01/25/21 Citi
Skyworks price target raised to $164 from $137 at Citi
01/11/21 BofA
Skyworks downgraded to Neutral from Buy at BofA
01/06/21 KeyBanc
Skyworks price target raised to $180 from $170 at KeyBanc
12/14/20 Goldman Sachs
Skyworks price target raised to $171 from $162
SWKS Skyworks
/

+

SWKS Skyworks
/

+

SWKS Skyworks
/

+

Recommendations
SiTime price target raised to $150 from $100 at Barclays » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
SITM

SiTime

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SITM SiTime
/

+

SITM SiTime
/

+

12/30/20 Roth Capital
SiTime price target raised to $130 from $110 at Roth Capital
11/25/20 Lynx
SiTime benefiting from October fire at AKM factory in Japan, says Lynx
11/05/20 Needham
SiTime price target raised to $105 from $75 at Needham
10/15/20 Roth Capital
SiTime price target raised to $110 from $80 at Roth Capital
SITM SiTime
/

+

  • 12
    Jun
SITM SiTime
/

+

Recommendations
Silicon Labs price target raised to $150 from $135 at Barclays » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
SLAB

Silicon Labs

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLAB Silicon Labs
/

+

SLAB Silicon Labs
/

+

01/25/21 Citi
Silicon Labs price target raised to $165 from $121 at Citi
01/19/21
Fly Intel: Top five analyst initiations
01/19/21 Morgan Stanley
Silicon Labs initiated with an Equal Weight at Morgan Stanley
12/30/20 Roth Capital
Silicon Labs price target raised to $140 from $120 at Roth Capital
SLAB Silicon Labs
/

+

Recommendations
Qualcomm price target raised to $150 from $135 at Barclays » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
QCOM

Qualcomm

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QCOM Qualcomm
/

+

QCOM Qualcomm
/

+

01/06/21 KeyBanc
Skyworks price target raised to $180 from $170 at KeyBanc
01/06/21 KeyBanc
Qualcomm price target raised to $180 from $175 at KeyBanc
01/05/21 Wells Fargo
Wells Fargo sees 'seamless transition' for new Qualcomm CEO
01/05/21 Canaccord
Qualcomm price target raised to $180 from $175 at Canaccord
QCOM Qualcomm
/

+

QCOM Qualcomm
/

+

QCOM Qualcomm
/

+

QCOM Qualcomm
/

+

Recommendations
Qorvo price target raised to $185 from $160 at Barclays » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
QRVO

Qorvo

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QRVO Qorvo
/

+

QRVO Qorvo
/

+

01/25/21 Citi
Qorvo price target raised to $188 from $144 at Citi
12/28/20 Mizuho
Qorvo price target raised to $180 from $155 at Mizuho
12/22/20 Benchmark
Qorvo price target raised to $185 from $155 at Benchmark
12/14/20 Goldman Sachs
Qorvo price target raised to $190 from $180 at Goldman Sachs
QRVO Qorvo
/

+

QRVO Qorvo
/

+

QRVO Qorvo
/

+

Earnings
Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

Consensus $8.99. Sees…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Recommendations
NXP Semiconductors price target raised to $200 from $150 at Barclays » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
NXPI

NXP Semiconductors

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXPI NXP Semiconductors
/

+

NXPI NXP Semiconductors
/

+

01/15/21 Truist
NXP Semiconductors price target raised to $209 from $165 at Truist
01/06/21 KeyBanc
NXP Semiconductors price target raised to $195 from $190 at KeyBanc
12/28/20 Mizuho
NXP Semiconductors price target raised to $173 from $155 at Mizuho
12/17/20 KeyBanc
NXP Semiconductors price target raised to $190 from $160 at KeyBanc
NXPI NXP Semiconductors
/

+

NXPI NXP Semiconductors
/

+

NXPI NXP Semiconductors
/

+

Hot Stocks
Genmab reports $4.109B in worldwide net trade sales of Darzalex in 2020 » 06:49
01/26/21
01/26
06:49
01/26/21
06:49
GMAB

Genmab

$42.68 /

-0.41 (-0.95%)

, JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

Genmab (GMAB) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMAB Genmab
$42.68 /

-0.41 (-0.95%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

GMAB Genmab
$42.68 /

-0.41 (-0.95%)

01/25/21 DNB Markets
Genmab downgraded to Sell from Hold at DNB Markets
01/19/21 Morgan Stanley
Genmab downgraded to Equal Weight on valuation at Morgan Stanley
01/19/21 Morgan Stanley
Genmab downgraded to Equal Weight from Overweight at Morgan Stanley
01/15/21 H.C. Wainwright
Genmab price target raised to $49 from $44 at H.C. Wainwright
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Recommendations
Nvidia price target raised to $600 from $550 at Barclays » 06:49
01/26/21
01/26
06:49
01/26/21
06:49
NVDA

Nvidia

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
/

+

NVDA Nvidia
/

+

01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/15/21 Truist
Nvidia price target raised to $672 from $643 at Truist
01/15/21 Susquehanna
Nvidia price target raised to $625 from $610 at Susquehanna
01/12/21 Wells Fargo
Nvidia very-well positioned as gaming momentum continues, says Wells Fargo
NVDA Nvidia
/

+

NVDA Nvidia
/

+

NVDA Nvidia
/

+

NVDA Nvidia
/

+

Recommendations
Maxim Integrated price target raised to $95 from $74 at Barclays » 06:49
01/26/21
01/26
06:49
01/26/21
06:49
MXIM

Maxim Integrated

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MXIM Maxim Integrated
/

+

MXIM Maxim Integrated
/

+

01/25/21 Deutsche Bank
Maxim Integrated price target raised to $101 from $95 at Deutsche Bank
12/17/20 Deutsche Bank
Maxim Integrated price target raised to $95 from $90 at Deutsche Bank
11/25/20 Truist
Analog Devices price target raised to $164 from $136 at Truist
08/20/20 RBC Capital
Analog Devices price target raised to $135 from $130 at RBC Capital
MXIM Maxim Integrated
/

+

Recommendations
Marvell price target raised to $60 from $50 at Barclays » 06:49
01/26/21
01/26
06:49
01/26/21
06:49
MRVL

Marvell

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
/

+

MRVL Marvell
/

+

01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/25/21 Citi
Marvell price target raised to $64 from $50 at Citi
01/15/21 Susquehanna
Marvell price target raised to $60 from $54 at Susquehanna
01/13/21 Piper Sandler
Marvell price target raised to $60 from $50 at Piper Sandler
MRVL Marvell
/

+

MRVL Marvell
/

+

MRVL Marvell
/

+

MRVL Marvell
/

+

Recommendations
Lam Research price target raised to $600 from $405 at Barclays » 06:48
01/26/21
01/26
06:48
01/26/21
06:48
LRCX

Lam Research

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
/

+

LRCX Lam Research
/

+

01/25/21 B. Riley Securities
Lam Research price target raised to $650 from $600 at B. Riley Securities
01/25/21 Credit Suisse
Lam Research price target raised to $650 from $450 at Credit Suisse
01/25/21 Deutsche Bank
Lam Research price target raised to $575 from $500 at Deutsche Bank
01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
LRCX Lam Research
/

+

LRCX Lam Research
/

+

LRCX Lam Research
/

+

LRCX Lam Research
/

+

Recommendations
KLA Corp. price target raised to $300 from $220 at Barclays » 06:48
01/26/21
01/26
06:48
01/26/21
06:48
KLAC

KLA Corp.

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KLAC KLA Corp.
/

+

KLAC KLA Corp.
/

+

01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/25/21 Citi
KLA Corp. price target raised to $360 from $236 at Citi
01/18/21 Goldman Sachs
KLA Corp. price target raised to $308 from $271 at Goldman Sachs
01/08/21 Argus
KLA Corp. price target raised to $300 from $235 at Argus
KLAC KLA Corp.
/

+

KLAC KLA Corp.
/

+

KLAC KLA Corp.
/

+

KLAC KLA Corp.
/

+

Recommendations
Broadcom price target raised to $500 from $450 at Barclays » 06:48
01/26/21
01/26
06:48
01/26/21
06:48
AVGO

Broadcom

$465.17 /

+0.57 (+0.12%)

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVGO Broadcom
$465.17 /

+0.57 (+0.12%)

AVGO Broadcom
$465.17 /

+0.57 (+0.12%)

01/13/21 Piper Sandler
AMD price target raised to $110 from $100 at Piper Sandler
01/11/21 JPMorgan
Broadcom ASIC revenues recently passed $1B, says JPMorgan
01/07/21 Piper Sandler
Piper boosts Broadcom target to $500, calls top large cap pick for 2021
12/30/20 Rosenblatt
Activist a 'new stage in the Intel journey of decline,' says Rosenblatt
AVGO Broadcom
$465.17 /

+0.57 (+0.12%)

AVGO Broadcom
$465.17 /

+0.57 (+0.12%)

AVGO Broadcom
$465.17 /

+0.57 (+0.12%)

AVGO Broadcom
$465.17 /

+0.57 (+0.12%)

Recommendations
II-VI price target raised to $100 from $65 at Barclays » 06:48
01/26/21
01/26
06:48
01/26/21
06:48
IIVI

II-VI

$91.44 /

-2.54 (-2.70%)

Barclays analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IIVI II-VI
$91.44 /

-2.54 (-2.70%)

IIVI II-VI
$91.44 /

-2.54 (-2.70%)

01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/25/21 Citi
II-VI price target raised to $110 from $65 at Citi
01/19/21 Needham
II-VI price target raised to $98 from $71 at Needham
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
IIVI II-VI
$91.44 /

-2.54 (-2.70%)

  • 02
    Jul
IIVI II-VI
$91.44 /

-2.54 (-2.70%)

IIVI II-VI
$91.44 /

-2.54 (-2.70%)

Hot Stocks
Merck: EC approves KEYTRUDA for treatment of MSI-H, dMMR colorectal cancer » 06:48
01/26/21
01/26
06:48
01/26/21
06:48
MRK

Merck

$81.15 /

+0.19 (+0.23%)

Merck announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

01/21/21 Wedbush
Scholar Rock price target raised to $66 from $47 at Wedbush
01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
01/20/21 Citi
Citi opens 'negative Catalyst Watch' on Bristol-Myers
01/06/21 Citi
Citi opens 'positive catalyst watch' on Merck
MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

MRK Merck
$81.15 /

+0.19 (+0.23%)

Recommendations
Applied Materials price target raised to $115 from $74 at Barclays » 06:47
01/26/21
01/26
06:47
01/26/21
06:47
AMAT

Applied Materials

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMAT Applied Materials
/

+

AMAT Applied Materials
/

+

06:44 Today DA Davidson
Applied Materials upgraded to Buy from Neutral at DA Davidson
01/25/21 Citi
Applied Materials price target raised to $130 from $80 at Citi
01/18/21 Goldman Sachs
Applied Materials price target raised to $118 from $99 at Goldman Sachs
01/11/21 BofA
BofA US 1 List changes
AMAT Applied Materials
/

+

AMAT Applied Materials
/

+

AMAT Applied Materials
/

+

AMAT Applied Materials
/

+

Recommendations
Analog Devices price target raised to $170 from $150 at Barclays » 06:47
01/26/21
01/26
06:47
01/26/21
06:47
ADI

Analog Devices

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
/

+

ADI Analog Devices
/

+

01/14/21 RBC Capital
Analog Devices price target raised to $174 from $150 at RBC Capital
01/06/21 KeyBanc
Analog Devices price target raised to $175 from $160 at KeyBanc
12/17/20 Deutsche Bank
Analog Devices price target raised to $150 from $142 at Deutsche Bank
12/16/20 Citi
Citi sees 'substantial upside' to semi estimates after latest checks
ADI Analog Devices
/

+

ADI Analog Devices
/

+

ADI Analog Devices
/

+

ADI Analog Devices
/

+

Initiation
Telefonica Brasil initiated with a Buy at UBS » 06:47
01/26/21
01/26
06:47
01/26/21
06:47
VIV

Telefonica Brasil

$8.39 /

+0.205 (+2.50%)

UBS initiated coverage of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIV Telefonica Brasil
$8.39 /

+0.205 (+2.50%)

10/15/20 Barclays
Telefonica Brasil price target lowered to $9.50 from $10.50 at Barclays
05/04/20 Credit Suisse
Telefonica Brasil upgraded to Outperform from Neutral at Credit Suisse
05/01/20 HSBC
Telefonica Brasil upgraded to Buy from Hold at HSBC
04/22/20 JPMorgan
Telefonica Brasil upgraded to Overweight from Neutral at JPMorgan
Recommendations
Allegro MicroSystems price target raised to $38 from $28 at Barclays » 06:46
01/26/21
01/26
06:46
01/26/21
06:46
ALGM

Allegro MicroSystems

$31.85 /

-1.57 (-4.70%)

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGM Allegro MicroSystems
$31.85 /

-1.57 (-4.70%)

12/28/20 Mizuho
Allegro MicroSystems price target raised to $30 from $28 at Mizuho
11/23/20 Jefferies
Allegro MicroSystems initiated with a Buy at Jefferies
11/23/20 Credit Suisse
Allegro MicroSystems initiated with an Outperform at Credit Suisse
11/23/20 Mizuho
Allegro MicroSystems initiated with a Buy at Mizuho
ALGM Allegro MicroSystems
$31.85 /

-1.57 (-4.70%)

  • 29
    Oct
ALGM Allegro MicroSystems
$31.85 /

-1.57 (-4.70%)

Earnings
Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 » 06:46
01/26/21
01/26
06:46
01/26/21
06:46
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Initiation
America Movil initiated with a Neutral at UBS » 06:45
01/26/21
01/26
06:45
01/26/21
06:45
AMX

America Movil

$14.44 /

+0.165 (+1.16%)

UBS initiated coverage of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMX America Movil
$14.44 /

+0.165 (+1.16%)

09/15/20 New Street
America Movil upgraded to Buy from Neutral at New Street
06/04/20 Itau BBA
America Movil upgraded to Outperform from Market Perform at Itau BBA
04/30/20
Fly Intel: Top five analyst initiations
04/30/20 Barclays
America Movil reinstated with an Overweight at Barclays
Downgrade
Flughafen Zuerich downgraded to Hold from Buy at Berenberg » 06:44
01/26/21
01/26
06:44
01/26/21
06:44
FLGZY

Flughafen Zuerich

$0.00 /

+ (+0.00%)

Berenberg analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLGZY Flughafen Zuerich
$0.00 /

+ (+0.00%)

01/20/21 Barclays
Flughafen Zuerich price target raised to CHF 166 from CHF 157 at Barclays
12/17/20 Morgan Stanley
Flughafen Zuerich price target raised to CHF 169 from CHF 164 at Morgan Stanley
12/04/20 Deutsche Bank
Flughafen Zuerich price target raised to CHF 182 from CHF 157 at Deutsche Bank
11/30/20 UBS
Flughafen Zuerich downgraded to Neutral from Buy at UBS
Upgrade
Applied Materials upgraded to Buy from Neutral at DA Davidson » 06:44
01/26/21
01/26
06:44
01/26/21
06:44
AMAT

Applied Materials

$108.14 /

+1.77 (+1.66%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMAT Applied Materials
$108.14 /

+1.77 (+1.66%)

AMAT Applied Materials
$108.14 /

+1.77 (+1.66%)

01/25/21 Citi
Applied Materials price target raised to $130 from $80 at Citi
01/18/21 Goldman Sachs
Applied Materials price target raised to $118 from $99 at Goldman Sachs
01/11/21 BofA
BofA US 1 List changes
01/07/21 Argus
Applied Materials price target raised to $110 from $90 at Argus
AMAT Applied Materials
$108.14 /

+1.77 (+1.66%)

AMAT Applied Materials
$108.14 /

+1.77 (+1.66%)

AMAT Applied Materials
$108.14 /

+1.77 (+1.66%)

AMAT Applied Materials
$108.14 /

+1.77 (+1.66%)

Hot Stocks
Synovus reports Q4 net interest margin 3.12%, up 2 bps vs. Q3  06:44
01/26/21
01/26
06:44
01/26/21
06:44
SNV

Synovus

$36.66 /

-0.63 (-1.69%)

 
ShowHide Related Items >><<
SNV Synovus
$36.66 /

-0.63 (-1.69%)

SNV Synovus
$36.66 /

-0.63 (-1.69%)

01/08/21 Piper Sandler
Synovus price target raised to $40 from $37 at Piper Sandler
01/07/21 Jefferies
Synovus upgraded to Buy with $40 price target at Jefferies
01/07/21 Jefferies
Synovus upgraded to Buy from Hold at Jefferies
12/11/20 RBC Capital
Synovus upgraded to Outperform on better credit and capital view at RBC Capital
SNV Synovus
$36.66 /

-0.63 (-1.69%)

SNV Synovus
$36.66 /

-0.63 (-1.69%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.